Trial intelligence / Profile preview

Remimazolam vs propofol for hemodynamics and recovery in elderly GI EMR

ChiCTR2500109016Phase 4Not yet recruiting

Sponsor
Jiangsu Provincial People's Hospital
Start
Sep 2025
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial in None comparing Remimazolam arm with Propofol arm (2 arms). Primary endpoints: Incidence of hypotension, Delirium and 1 more. Planned start Sep 2025; status: not yet recruiting.

02

Drugs

remimazolampropofol

Beyond the preview

Go deeper on ChiCTR2500109016.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2500109016.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call